Effects of Methimazole versus Propylthiouracil on soluble Fas level

被引：0
|
作者：
Majidi, M. [1 ]
Shooshtarizadeh, P. [1 ]
Haghpanah, V. [1 ]
Radfar, M.
Shirzad, N. [1 ]
Larijani, B. [1 ]
机构：
[1] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2011年 / 33卷 / 02期
关键词：
methimazole; propylthiouracil; sFas;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：454 / 454
页数：1
相关论文
共 50 条
  • [11] Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil
    Noh, Jaeduk Yoshimura
    Inoue, Kosuke
    Suzuki, Nami
    Yoshihara, Ai
    Fukushita, Miho
    Matsumoto, Masako
    Imai, Hideyuki
    Hiruma, Shigenori
    Ichikawa, Masahiro
    Koshibu, Masakazu
    Sankoda, Akiko
    Hirose, Rei
    Watanabe, Natsuko
    Sugino, Kiminori
    Ito, Koichi
    ENDOCRINE JOURNAL, 2024, 71 (07) : 695 - 703
  • [12] KINETIC DETERMINATION OF CARBIMAZOLE, METHIMAZOLE AND PROPYLTHIOURACIL IN PHARMACEUTICALS, ANIMAL FEED AND ANIMAL LIVERS
    GARCIA, MS
    ALBERO, MI
    SANCHEZPEDRENO, C
    TOBAL, L
    ANALYST, 1995, 120 (01) : 129 - 133
  • [13] The efficiency and safety of methimazole and propylthiouracil in hyperthyroidism A meta-analysis of randomized controlled trials
    Tan, Shuang
    Chen, Long
    Jin, Likun
    Fu, Xiaomin
    MEDICINE, 2021, 100 (30) : E26707
  • [14] METHIMAZOLE AND PROPYLTHIOURACIL INCREASE THYROGLOBULIN GENE-EXPRESSION IN FRTL-5 CELLS
    LEER, LM
    CAMMENGA, M
    DEVIJLDER, JJM
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1991, 82 (2-3) : R25 - R30
  • [15] EFFECTS OF METHIMAZOLE AND PROPYLTHIOURACIL ON GLUCOSE AND LIPID METABOLISM, SERUM THYROXINE, CYSTATIN C AND B2-MICROGLOBULIN IN PATIENTS WITH HYPERTHYROIDISM
    Luo, Yuting
    Zhang, Juan
    Luo, Jie
    Li, Yong
    ACTA MEDICA MEDITERRANEA, 2019, 35 (06): : 3035 - 3039
  • [16] Toxicities Associated with 1-month Treatment with Propylthiouracil (PTU) and Methimazole (MMI) in Male Rats
    Nambiar, Prashant R.
    Palanisamy, Gopinath S.
    Okerberg, Carlin
    Wolford, Angela
    Walters, Karen
    Buckbinder, Leonard
    Reagan, William J.
    TOXICOLOGIC PATHOLOGY, 2014, 42 (06) : 970 - 983
  • [17] Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan
    Huang, CN
    Hsu, TC
    Chou, HS
    Tsay, GJ
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2004, 103 (04) : 274 - 279
  • [18] A comparative study on the clinical efficacy and pregnancy outcomes of methimazole and propylthiouracil in managing pregnancy complicated with hyperthyroidism
    Hu, Wanjing
    Wang, Liangjiang
    Jiang, Julian
    Li, Jingwei
    Jiang, Lihong
    AFRICAN JOURNAL OF REPRODUCTIVE HEALTH, 2024, 28 (10): : 141 - 147
  • [19] Soluble Fas antigen and soluble Fas ligand in early neonatal life
    Sarandakou, A
    Protonotariou, E
    Rizos, D
    Soubassi, L
    Malamitsi-Puchner, A
    EARLY HUMAN DEVELOPMENT, 2003, 75 (1-2) : 1 - 7
  • [20] Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach
    He, Qingfeng
    Li, Min
    Ji, Peiying
    Zheng, Aole
    Yao, Li
    Zhu, Xiao
    Shin, Jae-Gook
    Lauschke, Volker M.
    Han, Bing
    Xiang, Xiaoqiang
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 491
12345